VBI VACCINES INC/BC
Profile
Company Names
VBI VACCINES INC/BC
LEVON RESOURCES LTD.
Addresses
160 SECOND STREET, FLOOR 3, CAMBRIDGE, MA 02142
222 THIRD STREET, SUITE 2241, CAMBRIDGE, MA 02142
570 GRANVILLE STREET, SUITE 900, VANCOUVER, A1 V6C 3P1
455 GRANVILLE STREET, SUITE 400, VANCOUVER, A1 V6C 1T1
Phone Numbers
(617) 830-3031
617-830-3031
604 682-3701
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, BIOTECHNOLOGY, OTHER
Year Incorporated:
> 5 years ago
State Incorporated:
BRITISH COLUMBIA, CANADA
Total Amount Raised:
$41,640,684.00
Number of Funding Rounds:
8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2022-09-14
$0.00
$0.00
$0.00
Equity
7
2020-05-22
$4,700,000.00
$4,700,000.00
$0.00
Equity
6
2020-04-24
$1,057,500.00
$1,057,500.00
$0.00
5
2018-12-04
$7,000,000.00
$7,000,000.00
$0.00
Equity
4
2016-12-06
$10,598,750.00
$10,598,750.00
$0.00
Equity
3
2016-06-20
$13,609,749.00
$13,609,749.00
$0.00
Equity
2
2014-10-21
$4,400,000.00
$4,400,000.00
$0.00
Equity
1
2010-08-31
$274,685.00
$274,685.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID
ANDERSON
EXECUTIVE OFFICER
PLX PHARMA INC
| AIKO BIOTECHNOLOGY INC
| EREWARDS INC
| HEADSPROUT INC
| FISKER AUTOMOTIVE INC
| MOLECULAR DETECTION, INC.
| FISKER HOLDINGS, INC.
| PLX PHARMA INC.
| E-REWARDS INC
| NANOSPECTRA BIOSCIENCES INC
| ALTA VENTURES MEXICO FUND I, L.P.
| VISION SCIENCES INC /DE/
| OFFERCLICK, INC.
| 838 OAK STREET LLC
| CAMBURY APARTMENTS LLC
| SYNERGY BIOMEDICAL, LLC
| EMBERCLEAR CORP.
| TRANSCENDENT CAFE LLC
| ONE PINE APARTMENTS, LLC
| LAKESHORE APARTMENTS, LLC
| VBI VACCINES INC.
| STEELWEDGE SOFTWARE INC
| PLACESTER, INC.
| CANADIAN INTERNATIONAL OIL CORP.
| FIREHOLE CRAFT BREWING CO
| FB2 SERVICES, INC.
| ACTUALMEDS CORP
| FPB FINANCIAL CORP
| VBI VACCINES INC/BC
| IBC ADVANCED ALLOYS CORP.
| ZSX MEDICAL, LLC
| NEXTSHIFT ROBOTICS INC.
| BASANITE, INC.
| LUNGLIFE AI, INC.
| BETTO, INC.
| ANABIOS CORP
| VERNAL BIOSCIENCES, INC.
| AVIDIAN GOLD CORP.
| GREENIDGE GENERATION HOLDINGS INC.
| CARMELL CORP
JEFF
BAXTER
EXECUTIVE OFFICER, DIRECTOR
SAM
CHAWLA
DIRECTOR
STEVE
GILLIS
DIRECTOR
XORI CORP
| ONCOFACTOR CORP
| VARIATION BIOTECHNOLOGIES (US), INC.
| LYCERA CORP
| VBI VACCINES INC.
| ONCORESPONSE INC
| LODO THERAPEUTICS CORP
| PETRA PHARMA CORP
| APOGEN BIOTECHNOLOGIES, INC.
| RODEO THERAPEUTICS CORP
| PRONIRAS CORP
| MAGNOLIA NEUROSCIENCES CORP
| VBI VACCINES INC/BC
| ALLY THERAPEUTICS, INC.
| SKYLARK BIO, INC.
| BASKING BIOSCIENCES, INC.
STEVEN
GILLIS
DIRECTOR
TRUBION PHARMACEUTICALS, INC
| PHASERX INC
| PULMATRIX INC
| THERACLONE SCIENCES, INC.
| MIRINA CORP
| SURFACE LOGIX INC
| ACYLIN THERAPEUTICS, INC.
| BLUEBIRD BIO, INC.
| VARIATION BIOTECHNOLOGIES (US), INC.
| GROOVE BIOPHARMA CORP
| ALLOZYNE INC
| PHASERX, INC.
| VIRAL LOGIC SYSTEMS TECHNOLOGY CORP
| FARADAY PHARMACEUTICALS, INC.
| PULMATRIX OPERATING COMPANY, INC.
| LYCERA CORP
| PULMATRIX, INC.
| NEXGENIA INC.
| CODIAK BIOSCIENCES, INC.
| VBI VACCINES INC/BC
| NOHLA THERAPEUTICS INC.
| HOMOLOGY MEDICINES, INC.
| IMMUSANT, INC.
| ONCORESPONSE INC
| EGENESIS, INC.
| ARCH VENTURE FUND X, L.P.
| ARCH VENTURE FUND X OVERAGE, L.P.
| ARCH VENTURE FUND XI, L.P.
| HC BIOSCIENCE, INC.
| ARCH VENTURE FUND XII, L.P.
| PHEAST THERAPEUTICS, INC.
| SONOTHERA, INC.
| PRONIRAS CORP
| ONCORESPONSE, INC
TOMER
KARIV
DIRECTOR
JAMES
MARTIN
EXECUTIVE OFFICER
DESIGNLINE INTERNATIONAL CORP
| JASPER VENTURES INC.
| INTERNATIONAL MONEY MANAGEMENT, INC.
| ST. JOHN CV CO-MANAGEMENT COMPANY, LLC
| FRESENIUS VASCULAR CARE MEMPHIS MSO, LLC
| VAPOR CORP.
| VBI VACCINES INC/BC
| MOTUS GI HOLDINGS, INC.
| MOTUS GI MEDICAL TECHNOLOGIES, LTD.
| COCRYSTAL PHARMA, INC.
| ERIE DOWNTOWN EQUITY FUND, LLC
| RALLYCORP, INC.
| NORDWAND SPECIAL OPPORTUNITIES II LLC
| NORDWAND EARLY OPPORTUNITIES I LLC
| NORDWAND HEALTHCARE OPPORTUNITIES I LLC
| NORDWAND SPECIAL OPPORTUNITIES III LLC
EGIDIO
NASCIMENTO
EXECUTIVE OFFICER
SCOTT
REQUADT
DIRECTOR
STEVEN
RUBIN
DIRECTOR
LISA
SHARP
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-09-14
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-05-22
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-12-04
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-12-06
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
